Lungs intersticial damage and its diagnosis in scleroderma (systemic sclerosis)

Lungs intersticial damage and its diagnosis in scleroderma (systemic sclerosis)

Saved in:

Bibliographic Details
Main Authors:	L V Teplova, L P Ananyeva
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2008-12-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/627
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interstitial lung disease in systemic sclerosis (systemic scleroderma)
by: L. P. Ananyeva, et al.
Published: (2021-03-01)

Diagnosis and treatment of interstitial lung disease in scleroderma systematica
by: L. P. Ananyeva
Published: (2018-06-01)

The use of the Scleroderma Clinical Trials Consortium Damage Index in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2025-03-01)

SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION
by: Lyudmila Valeryevna Teplova, et al.
Published: (2010-06-01)

CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA
by: L P Anan'eva, et al.
Published: (2011-04-01)

ULTRASOUND SCANNING: POSSIBILITIES AND PROSPECTS OF EVALUATING LUNG INVOLVEMENT IN SYSTEMIC SCLERODERMA
by: Olga Borisovna Ovsyannikova, et al.
Published: (2012-12-01)

Autologous hematopoietic stem cell transplantation for systemic scleroderma
by: R T Alekperov, et al.
Published: (2012-08-01)

Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease
by: Olga Borisovna Ovsyannikova, et al.
Published: (2013-06-01)

Prospects for using mycophenolate mofetil in diffuse scleroderma
by: L P Ananyeva
Published: (2009-03-01)

UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT
by: R. T. Alekperov, et al.
Published: (2014-09-01)

INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2017-03-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Application of the Scleroderma Clinical Trials Consortium Damage Index in patients with juvenile systemic sclerosis
by: Caihui Zhang, et al.
Published: (2025-05-01)

Use of the international systemic scleroderma activity index
by: Maya Nikolayevna Starovoitova, et al.
Published: (2013-03-01)

THE MAIN RESULTS OF COOPERATION BETWEEN THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY AND RESEARCH CENTERS OF EUROPE WITHIN THE EUSTAR (EULAR SCLERODERMA TRIALS AND RESEARCH GROUP) IN SYSTEMIC SCLEROSIS
by: L. P. Ananyeva, et al.
Published: (2014-12-01)

Positivity for antiribonucleoprotein antibodies in rheumatic diseases: focus on scleroderma systematica
by: R. U. Shayakhmetova, et al.
Published: (2018-01-01)

Early systemic scleroderma: a current diagnostic algorithm (a lecture)
by: Lidia Petrovna Ananyeva
Published: (2012-04-01)

Prevalence and risk factors of interstitial lung disease in early systemic sclerosis and systemic sclerosis sine scleroderma: a cross-sectional study
by: Maria Carolina Torres Villarreal, et al.
Published: (2025-01-01)

Development of a conceptual model of early systemic sclerosis (scleroderma)
by: William R. Lenderking, et al.
Published: (2025-08-01)

From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution
by: Giuggioli Dilia, et al.
Published: (2018-01-01)

The resolution of the Expert Council on Interstitial Lung Diseases in Systemic Scleroderma (Moscow, October 14, 2019)
by: S. N. Avdeev, et al.
Published: (2020-03-01)

NEW CLASSIFICATION CRITERIA FOR SCLERODERMA SYSTEMATICA (a lecture)
by: Lidia Petrovna Ananyeva
Published: (2013-12-01)

Biomarkers of interstitial lung disease in systemic scleroderma and their significance
by: D. V. Khorolsky, et al.
Published: (2023-02-01)

ESOPHAGEAL PATHOLOGY IN SCLERODERMA SYSTEMATICA: CLINICAL AND ENDOSCOPIC FINDINGS
by: A E Karateev, et al.
Published: (2012-02-01)

DIFFERENTIAL DIAGNOSIS IN JUVENILE SCLERODERMA
by: M.K. Osminina, et al.
Published: (2008-01-01)

DIAGNOSIS OF PULMONARY HYPERTENSION IN SCLERODERMA SYSTEMATICA
by: A V Volkov, et al.
Published: (2008-12-01)

PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2016-02-01)

RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA
by: Lidia Petrovna Ananieva, et al.
Published: (2013-12-01)

Immunological features in anti-U1-ribonucleoprotein antibody positive patients with systemic scleroderma
by: R. U. Shayakhmetova, et al.
Published: (2020-03-01)

La lectura intersticial del cine intercultural
by: Vicente Castellanos
Published: (2018-09-01)

Gravidez Ectópica Intersticial: Um Caso Raro
by: Inês Jorge, et al.
Published: (2025-05-01)

El territorio intersticial de lo cotidiano
by: Leonardo Seguel Briones
Published: (2001-07-01)

EFFECT OF AT ORVASTATIN ON THE TIME COURSE OF CHANGESIN INFLAMMATORY MARKERS IN SYSTEMIC SCLERODERMA
by: R T Alekperov, et al.
Published: (2011-04-01)

Late Diagnosis of Systemic Scleroderma with Vascular Events: Clinical Case
by: Julia S. Bogomolova, et al.
Published: (2024-12-01)

THE REAL PREVALENCE OF EROSIVE ESOPHAGITIS AND BARRETT'S ESOPHAGUS IN SYSTEMIC SCLERODERMA: DATA FROM 12-MONTHS PROSPECTIVE STUDY
by: Andrey Evgenievich Karateev, et al.
Published: (2012-10-01)

Interstitial lung disease in patients with systemic scleroderma: approaches to predicting lesion volume
by: D. V. Khorolsky, et al.
Published: (2024-01-01)

Castleman’s Disease. Association with System Scleroderma
by: A. V. Yagoda, et al.
Published: (2023-10-01)

CLINICAL ASSOCIATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS TYPE 2 RECEPTOR IN SYSTEMIC SCLEROSIS
by: R. T. Alekperov, et al.
Published: (2018-11-01)

Treatment for systemic scleroderma
by: Rezvaya Tairovich Alekperov, et al.
Published: (2011-09-01)

Mesalazine-induced intersticial pneumonitis in patients with ulcerative colitis
by: Elena Prado Mel, et al.
Published: (2016-01-01)